会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Pharmaceutical use of Graptopetalum and related plants
    • Graptopetalum及相关植物的药用
    • US07364758B2
    • 2008-04-29
    • US10931791
    • 2004-08-31
    • Shih-Lan Hsu
    • Shih-Lan Hsu
    • A01N65/00A61K36/00
    • A61K36/41Y10S514/838Y10S514/893Y10S514/894
    • The present invention relates to compositions comprising Graptopetalum and uses thereof Graptopetalum can protect animals from liver diseases and medical conditions, such as inflammation, steatosis, and fibrosis. In particular, Graptopetalum inhibits proliferation of activated hepatic stellate cells, which play a pivotal role in liver fibrosis. Graptopetalum also has anti-fibrosis activities as well as inhibits proliferation of lung fibroblasts. Therefore, in addition to being a prophylactic and therapeutic agent for the liver, Graptopetalum is useful against fibrosis or inflammation of tissues or organs other than the liver, in particular lung, kidney, and bladder. Other plants in the family of Crassulaceae, particularly Echeveria, have similar effects as Graptopetalum.
    • 本发明涉及包含Graptopetalum的组合物及其用途Graptopetalum可以保护动物免受肝脏疾病和医学病症如炎症,脂肪变性和纤维化。 特别是,Graptopetalum抑制活化肝星状细胞的增殖,其在肝纤维化中起关键作用。 Graptopetalum还具有抗纤维化活性以及抑制肺成纤维细胞的增殖。 因此,Graptopetalum除了作为肝脏的预防和治疗剂之外,还可用于除了肝脏,特别是肺,肾和膀胱以外的组织或器官的纤维化或炎症。 十字花科的其他植物,尤其是Echeveria,具有与Graptopetalum类似的作用。
    • 10. 发明申请
    • Pharmaceutical use of Graptopetalum and related plants
    • Graptopetalum及相关植物的药用
    • US20060045925A1
    • 2006-03-02
    • US10931791
    • 2004-08-31
    • Shih-Lan Hsu
    • Shih-Lan Hsu
    • A61K36/754
    • A61K36/41Y10S514/838Y10S514/893Y10S514/894
    • The present invention relates to compositions comprising Graptopetalum and uses thereof Graptopetalum can protect animals from liver diseases and medical conditions, such as inflammation, steatosis, and fibrosis. In particular, Graptopetalum inhibits proliferation of activated hepatic stellate cells, which play a pivotal role in liver fibrosis. Graptopetalum also has anti-fibrosis activities as well as inhibits proliferation of lung fibroblasts. Therefore, in addition to being a prophylactic and therapeutic agent for the liver, Graptopetalum is useful against fibrosis or inflammation of tissues or organs other than the liver, in particular lung, kidney, and bladder. Other plants in the family of Crassulaceae, particularly Echeveria, have similar effects as Graptopetalum.
    • 本发明涉及包含Graptopetalum的组合物及其用途Graptopetalum可以保护动物免受肝脏疾病和医学病症如炎症,脂肪变性和纤维化。 特别是,Graptopetalum抑制活化肝星状细胞的增殖,其在肝纤维化中起关键作用。 Graptopetalum还具有抗纤维化活性以及抑制肺成纤维细胞的增殖。 因此,Graptopetalum除了作为肝脏的预防和治疗剂之外,还可用于除了肝脏,特别是肺,肾和膀胱以外的组织或器官的纤维化或炎症。 十字花科的其他植物,尤其是Echeveria,具有与Graptopetalum类似的作用。